June 1, 2012
Drug risks are often found after market approval. This article reviews prior literature on how the U.S. Food and Drug Administration (FDA) communicates risks to the general public and providers, and its impact on drug utilization, health outcomes, a ...
August 1, 2012
While the 1983 Orphan Drug Act led to a boom in development and production of orphan drugs, inattentive regulatory standards may imperil patients with rare diseases.
October 10, 2013
Human Capital Blog
Around the country, print, broadcast, and online media outlets are covering the groundbreaking work of RWJF leaders, scholars, fellows, alumni, and grantees.